Janssen Reports Switching to SYMTUZA ™ Results in Maintained High Virologic Suppression and No Resistance Development up to 96-Weeks in Virologically Suppressed Adults with HIV-1

Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news